Caixin
Caixin Global – Latest China News & Headlines

Home >

ABOUT US

CX Tech is Caixin Global's real-time tech news portal, featuring 24-hour news, short-form analysis, and roundups from business and tech media in China.

LATEST
Intel Pivots to Custom Chips to Tap China’s Trillion-Yuan Computing Markets
Geely Leads $141 Million Round for Tsinghua-Linked Robotics Startup
China’s Giant Neutrino Detector Delivers First Results With Record Precision
China Unicom Taps Veteran Executive as Chairman to Navigate Telecom Transition
Chinese Self-Driving Firms Accelerate Into Middle East, Southeast Asia
Baidu Posts Record Revenue Decline as Ad Business Falters
Xiaomi’s EV, AI Units Post First Quarterly Profit
China’s Agricultural Drone Makers Pivot to Smarter Navigation as Size Race Ends
Alibaba Renames AI App to Stand Out in China’s Crowded Chatbot Market
Investors Flock to Chinese eVTOLs Chasing Regulatory Green Lights
Nexperia Headquarters Rachets Up Feud With China Unit With Salvo of Accusations
Robot-Maker Unitree Steps Closer to China IPO
Tencent Says Talks With Apple on WeChat Game Fees Are Advancing
Baidu Unveils Ambitious AI Chip Roadmap, Targeting 1 Million-Card Cluster by 2030
Tencent’s Profit Rises 19% on Overseas Gaming and AI-Powered Ad Surge
Caixin Summit: Design, Commercialization Key to China’s Low-Altitude Economy Taking Off, Industry Insider Says
China’s Robotics Revenue Soars as Industry Races to Crack Embodied AI
U.S. Formally Suspends Sweeping Export Control Rule for One Year After China Trade Talks
XAG Bets on Smart Farm Tech as Drone Turf Gets Crowded
Nexperia China Chip Supplies to Soon Resume, Dutch Official Says
Genome Giant Denies Falsifying Revenue Data

By Wang Luyao and Tang Ziyi / Apr 09, 2019 12:22 PM / Business & Tech

Photo: VCG

Photo: VCG

Chinese genome giant BGI Genomics denies it falsified profit records after a securities regulator said the company had inflated its 2017 income by millions of yuan.

Shenzhen's Securities Regulatory Commission said the company exaggerated its project business income for 2017 by 13.3 million yuan ($1.98 million), and its net profit from its project business by 12.4 million yuan, according to a statement filed by BGI last week.

BGI said on Sunday that the revenue discrepancy was caused by “irregular” accounting standards and that the company has taken measures to update its data in accordance with regulations.

Related: Gene-Sequencer Illumina Faces Tough Competition as It Officially Enters China


Share this article
Open WeChat and scan the QR code